Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction

Category Primary study
Registry of TrialsISRCTN registry
Year 2006
Demonstrate the superiority of ivabradine over placebo in the reduction of cardiovascular mortality and hospitalisations for worsening heart failure.
Epistemonikos ID: 3098c8bee774981abc45b417007065346af4089b
First added on: Jun 01, 2016